《新生物技术》是欧洲生物技术联合会(EFB)的官方期刊，双月刊。它涵盖了生物技术科学及其周围的政治、商业和金融环境。该杂志发表同行评议的基础研究论文、权威评论、专题文章和生物技术所有领域的观点。它反映了当前生物技术科学的充分多样性，特别是那些在研究和实践方面取得的进展，这些进展为商业或其他方面利用知识提供了机会，同时也为人们普遍关心和关心的更广泛的问题提供了新闻、讨论和评论。前景是完全国际化的。该杂志的范围包括生物技术的研究、工业和商业方面，涉及的领域包括:医疗保健和制药;粮食和农业;生物燃料;基因工程与分子生物学;基因组学和合成生物学;纳米技术;环境和生物多样性;生物催化;生物修复;过程工程。该杂志以科学的方法处理非科学问题，并就安全、监管、国际关系、公众看法、伦理和社会方面、教育和研究资助等问题发表评论。
http://ees.elsevier.com/nbt/
New Biotechnology is the official journal of the European Federation of Biotechnology (EFB) and is published bimonthly. It covers both the science of biotechnology and its surrounding political, business and financial milieu. The journal publishes peer-reviewed basic research papers, authoritative reviews, feature articles and opinions in all areas of biotechnology. It reflects the full diversity of current biotechnology science, particularly those advances in research and practice that open opportunities for exploitation of knowledge, commercially or otherwise, together with news, discussion and comment on broader issues of general interest and concern. The outlook is fully international.The scope of the journal includes the research, industrial and commercial aspects of biotechnology, in areas such as: Healthcare and Pharmaceuticals; Food and Agriculture; Biofuels; Genetic Engineering and Molecular Biology; Genomics and Synthetic Biology; Nanotechnology; Environment and Biodiversity; Biocatalysis; Bioremediation; Process engineering.The journal takes a scientific approach to non-scientific issues, and also comments on matters of safety, regulation, international relations, public perceptions, ethical and societal aspects, education, and research funding.
